Abstacts & lectures

Abstract Book

pdf   ABSTRACT_BOOK.pdf  (206 Kb)

Main Lectures


Opening lecture

The discovery of Clostridium and its clinical impact. An insight in the history of medicine

Roland Koerner, Sunderland Royal Hospital, Sunderland, UK

pdf   Roland_Koerner.pdf  (1820 Kb)

Clostridia in general, their toxins and other pathogenicity factors

Basis of the mode of action of clostridial toxins

Michel-Robert Popoff, Institut Pasteur, Paris, F

pdf   MR_Popoff.pdf  (1152 Kb)

Insights into the mechanism of botulinum neurotoxin (BoNT) receptor binding and substrate cleavage from a structural perspective

Axel T. Brunger, Howard Hughes Medical Institute, Stanford, USA

pdf   Axel_Brunger.pdf  (2638 Kb)

C. perfringen sepsilon-toxin

Juan Blasi, University of Barcelona, Barcelona, ES

pdf   Juan_Blasi.pdf  (17844 Kb)

Comparative genomics of clostridia and pathogenic properties

Holger Brüggemann, Max Planck Institute for Infection Biology, Berlin, DE

pdf   Holger_Brueggemann.pdf  (5640 Kb)

C. difficile

Clostridium difficile: an overview of the changes in our understanding the organism over the last 30 years

Maja Rupnik, Instituteof Public Health, Maribor, Slovenia

pdf   Maja_Rupnik.pdf  (521 Kb)

C. difficile- the wider perspective (humans, animals, environment)

Viveca Båverud,National Veterinary Institute, Uppsala, SE

pdf   Viveca_Baverud.pdf  (4819 Kb)

Clostridium difficile: an overview of the disease, host defences, risk factors and changing host susceptibility

Ian R. Poxton, Centre for Infectious Diseases, Edinburgh, UK

pdf   Ian_Poxton.pdf  (887 Kb)

Clinical spectrum of Clostridium difficile Infection (CDI) and the emergence of hypervirulent strains

Ed J. Kuijper, Centre for Infectious Diseases, Leiden, NL

pdf   Ed_kuijper.pdf  (2939 Kb)

Clostridia: clinical issues

Clostridial infections in the immunocompromised host

David Dockrell, Royal Hallamshire Hospital, Sheffield, UK

pdf   David_Dockrell.pdf  (2472 Kb)

Emerging clostridial infections in USA

L. Clifford McDonald, Centers for Disease Control and Prevention, Atlanta, USA

pdf   Clifford_McDonald.pdf  (1386 Kb)

Clostridia in cancer therapy

Jan Theys,University Maastricht, Maastricht, NL

pdf   Jan_Theys.pdf  (1192 Kb)

Toll-like receptors and intestinal inflammation

William F. Stenson,WashingtonUniversity Schoolof Medicine, St-Louis, USA

pdf   William_Stenson.pdf  (7240 Kb)

Afternoon sessions

Regulation of Clostridium difficile toxin expression

Jeroen Corver, Leiden University Medical Center, Leiden, NL

Structure-function analysis of Clostridium difficile toxin E expressed

in Escherichia coli

Alexandra Olling, Hannover Medical School, Hannover, DE

Genotyping of Clostridium difficile in Finland, 2007-2008

Saara Kotila, National Public Health Institute of Finland, Helsinki, FIN

pdf   Saara.Kotila.pdf  (240 Kb)

Emergence of Clostridium difficile infection due to a new hypervirulent strain, PCR-ribotype 078

Abraham Goorhuis, Leiden University Medical Center, Leiden, NL

pdf   Abraham.Goorhuis.pdf  (419 Kb)

Clinical-epidemiological characterization

of Clostridium difficile-Ribotype 053 - a new strain with high transmissibility

Markus Hell, University Hospital Salzburg, Salzburg, Austria

pdf   Markus.Hell.pdf  (382 Kb)

Characterization of Clostridium difficile ribotype 078 from human

and animal origin

Dennis Bakker, Leiden Universty Medical Hospital, Leiden, NL

pdf   Denis.Bakker.pdf  (277 Kb)

Isolation of Clostridium difficile from domestic and wild avian species

Mateja Zemljic, Institute of Public Health Maribor, Maribor, Slovenia

pdf   Mateja_Zemljic.pdf  (471 Kb)

Clinical significance of clostridial bacteremia: a retrospective three-year analysis in a French University Hospital Center

Alain Lozniewski, University Hospital Center of Nancy, Nancy, F

pdf   Alain.Lozniewski.pdf  (135 Kb)

Risk factors for Clostridium difficile infections in an endemic setting

in The Netherlands

Abraham Goorhuis, Leiden University Medical Center, Leiden, NL

pdf   Abraham.Goorhuis-2.pdf  (55 Kb)

 in this site:

CH-1015 Lausanne  - Switzerland  -  Phone +41 21 692 56 00  -  Fax  +41 21 692 56 05